Global Congestive Heart Failure (CHF) Treatment Device Market Research Report (up to 2027)
Global Congestive Heart Failure (CHF) Treatment Device Market (up to 2027): By Product, By End User, By Region
360iResearch predicts that the global market size for congestive heart failure (CHF) treatment devices, which was $10.67 billion in 2021, will expand to $11.51 billion in 2022 and grow at a CAGR of 8.05% to reach $16.99 billion by 2027. This report comprehensively analyzes the global market for CHF treatment devices, including sections on introduction, research methodology, executive summary, market overview, market insights, product analysis (cardiac resynchronization therapy, implantable defibrillators, pacemakers, ventricular assist devices), end-user analysis (outpatient surgery centers, hospitals & clinics), regional analysis (North America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.
- Company：マーケットリサーチセンター
- Price：Other
